483 SpecGx Sep 2019

483 SpecGx Sep 2019

Robert Ham FDA, Wayne Mcgrath FDA, Sarah Rhoades FDA, Ana Sandee FDA$595.00 - Available Now

FDA investigators audited the SpecGx - Saint Louis, MO, United States facility and issued inspectional observations (via FDA 483) on 12 Sep 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 12 Sep 2019
  • Location: Saint Louis, United States
  • FEI: 1940521
Add To Cart